FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Rohto-Mentholatum (Vietnam) Rohto Cooling Eye Drops Optic Glow Recall

Rohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0

Rohto-Mentholatum (Vietnam) Co., Ltd. · Ho Chi Minh, N/A

Risk level
Class II
Reported by FDA
Jul 29, 2026
Recall ID
D-0718-2026
Check your lot numberHow we source this data

Summary

Rohto-Mentholatum (Vietnam) recalled Rohto Cooling Eye Drops Optic Glow starting Jul 14, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0718-2026 on Jul 29, 2026. Reason: Lack of Assurance of Sterility. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility

Product description

Rohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0.03%, povidone 0.5%, propylene glycol 0.2%), Sterile, 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742010916, NDC 10742-8160-1

Lot numbers, UPCs & expiration codes

Lot #: 3H1V, 3H1VA, Exp. Date 2025/07; 3J1V, 3J2V, Exp. Date 2025/09; 3K1V, Exp. Date 2025/10; 4F1V, Exp. Date 2027/05; 4F1VA, Exp. Date 2027/05; 4H1V, Exp. Date 2027/07; 4I1V, Exp. Date 2027/08; 4K1V, 4K2V,Exp. Date 2027/10; 5A1V, 5A2V, Exp. Date 2027/12; 5D1V, Exp. Date 2028/03; 5E1V, Exp. Date2028/04; 5J1V, 5J2V, Exp. Date 2028/09; 6B1V, Exp. Date 2029/01; 6C1V, 6C1VA, 6C1VB, Exp. Date 2029/02.

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0718-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jul 14, 2026
FDA report date
Jul 29, 2026
Quantity
1,278,457 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Rohto-Mentholatum (Vietnam) Co., Ltd.

Original FDA data

Every field from FDA enforcement report D-0718-2026, exactly as published.

Show all FDA fields
City
Ho Chi Minh
Status
Ongoing
Country
Vietnam
Event ID
99440
Address
No. 16 Vsip, Street No. 5
Address (line 2)
Vietnam Singapore Industrial Park
Code information
Lot #: 3H1V, 3H1VA, Exp. Date 2025/07; 3J1V, 3J2V, Exp. Date 2025/09; 3K1V, Exp. Date 2025/10; 4F1V, Exp. Date 2027/05; 4F1VA, Exp. Date 2027/05; 4H1V, Exp. Date 2027/07; 4I1V, Exp. Date 2027/08; 4K1V, 4K2V,Exp. Date 2027/10; 5A1V, 5A2V, Exp. Date 2027/12; 5D1V, Exp. Date 2028/03; 5E1V, Exp. Date2028/04; 5J1V, 5J2V, Exp. Date 2028/09; 6B1V, Exp. Date 2029/01; 6C1V, 6C1VA, 6C1VB, Exp. Date 2029/02.
Report date
Jul 29, 2026
Product type
Drugs
Recall number
D-0718-2026
Classification
Class II
Recalling firm
Rohto-Mentholatum (Vietnam) Co., Ltd.
Product quantity
1,278,457 cartons
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Rohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0.03%, povidone 0.5%, propylene glycol 0.2%), Sterile, 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742010916, NDC 10742-8160-1
Distribution pattern
Nationwide within the United States
Recall initiation date
Jul 14, 2026
Initial firm notification
Letter
Center classification date
Jul 23, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0718-2026, published Jul 29, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls